Literature DB >> 17222651

Is the metabolic syndrome an independent risk factor for erectile dysfunction?

Stefan Heidler1, Christian Temml, Clemens Broessner, Karl Mock, Michael Rauchenwald, Stephan Madersbacher, Anton Ponholzer.   

Abstract

PURPOSE: We determined the role of the metabolic syndrome as an independent risk factor for erectile dysfunction.
MATERIALS AND METHODS: Men participating in a health screening project completed the International Index of Erectile Function-5. The metabolic syndrome was defined according to the 2005 International Diabetes Federation consensus definition. Multiple linear regression, ANOVA and chi-square tests were used to investigate the impact of the metabolic syndrome on erectile dysfunction.
RESULTS: A total of 2,371 men with a mean age of 46.1 years (SD 9.9, range 30 to 69) were analyzed. Of the men 33.4% (652) had no erectile dysfunction (International Index of Erectile Function-5 score 22 to 25), 59.7% (1,166) had mild erectile dysfunction (International Index of Erectile Function-5 score 17 to 21) and 6.9% (134) had moderate to severe erectile dysfunction (International Index of Erectile Function-5 score 5 to 16). The metabolic syndrome was present in 33.8% (794). In a multiple linear regression analysis an increased waist-to-hip ratio (p = 0.01) and metabolic syndrome (p = 0.01) turned out to be independently associated with a decreased International Index of Erectile Function-5 score. When stratified according to age, the metabolic syndrome was correlated to erectile dysfunction only in men 50 years old or older with an increase of severe erectile dysfunction by 48% (p = 0.01).
CONCLUSIONS: The metabolic syndrome and an increased waist-to-hip ratio are independently associated with a decreased International Index of Erectile Function-5 score. The metabolic syndrome in men older than 50 years is significantly associated with a higher proportion of moderate to severe erectile dysfunction.

Entities:  

Mesh:

Year:  2007        PMID: 17222651     DOI: 10.1016/j.juro.2006.09.043

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  28 in total

Review 1.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

2.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

Review 3.  Emerging role for TNF-α in erectile dysfunction.

Authors:  Fernando S Carneiro; Robert Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

4.  Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction.

Authors:  Aviva E Weinberg; Michael Eisenberg; Chirag J Patel; Glenn M Chertow; John T Leppert
Journal:  J Sex Med       Date:  2013-09-09       Impact factor: 3.802

5.  [Erectile dysfunction].

Authors:  Brigitte Esterbauer; Andreas Jungwirth
Journal:  Wien Med Wochenschr       Date:  2009

Review 6.  Testosterone supplementation therapy in the treatment of patients with metabolic syndrome.

Authors:  Jason R Kovac; Jason Kovac; Alexander W Pastuszak; Dolores J Lamb; Larry I Lipshultz
Journal:  Postgrad Med       Date:  2014-11       Impact factor: 3.840

Review 7.  [Primary and secondary prevention of erectile dysfunction].

Authors:  A Kaminsky; H Sperling; G Popken
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

8.  The impact of metabolic syndrome on retinal findings in patients with erectile dysfunction.

Authors:  Melih Balcı; Yılmaz Aslan; Berçem Bozarslan; Altuğ Tuncel; Mustafa Kayalı; Ali Atan
Journal:  Turk J Urol       Date:  2013-03

9.  Improvement of erectile function by Korean red ginseng (Panax ginseng) in a male rat model of metabolic syndrome.

Authors:  Sung-Dae Kim; Young-Joo Kim; Jung-Sik Huh; Sae-Woong Kim; Dong-Wan Sohn
Journal:  Asian J Androl       Date:  2013-02-04       Impact factor: 3.285

10.  TNF-alpha infusion impairs corpora cavernosa reactivity.

Authors:  Fernando S Carneiro; Saiprazad Zemse; Fernanda R C Giachini; Zidonia N Carneiro; Victor V Lima; R Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.